Serum IL-1β as a Novel Predictor of No-Reflow in STEMI Patients Under

Introduction

Acute ST-segment elevation myocardial infarction (STEMI) remains a leading cause of global mortality and disability,^1–3 necessitating rapid revascularization to salvage ischemic myocardium. Primary percutaneous coronary…